We Make Blood.
Our Serum Alternatives Perform Just Like Traditional Blood Serum, Offering Unmatched Consistency Across Cell Culture Applications.
How Can We Help You?
-
THERAPEUTICS
Donor-Free, Consistent Manufacturing
Our technology minimizes batch variation, enhancing drug development with a reliable, donor-free solution.
-
REJUVENATION
Revolutionizing Skin and Hair Regeneration
Our human serum alternative works universal and has been proven effective at growing stem cells, fibroblasts, and skin cells without the need for any blood serum.
-
CULTIVATED MEAT
Cutting Cultivated Meat Costs
Our livestock serum alternative slashes growth medium costs by up to 95%, making cultivated meat an affordable reality for the future.
-
RED BLOOD CELLS
Cost-Effective, Plasma-Free Red Blood Cells
By eliminating plasma from the growth process, we're setting new standards for affordable and sustainable production of red blood cells.
THERAPEUTICS
Donor-Free, Consistent Manufacturing
Our technology minimizes batch variation, enhancing drug development with a reliable, donor-free solution.
REJUVENATION
Revolutionizing Skin and Hair Regeneration
Our human serum alternative works universal and has been proven effective at growing stem cells, fibroblasts, and skin cells without the need for any blood serum.
CULTIVATED MEAT
Cutting Cultivated Meat Costs
Our livestock serum alternative slashes growth medium costs by up to 95%, making cultivated meat an affordable reality for the future.
RED BLOOD CELLS
Cost-Effective, Plasma-Free Red Blood Cells
By eliminating plasma from the growth process, we're setting new standards for affordable and sustainable production of red blood cells.
Meet Wasna
Wasna, inspired by the Dutch for 'what comes after,' is dedicated to transforming life sciences with synbio blood alternatives. Our mission is to provide ethical, sustainable alternatives, driven by a team committed to aligning scientific progress with ethical standards.
Together, we're not merely envisioning the possibilities of 'what comes after'—we're actively shaping it, paving the way for innovations that promise to redefine our understanding and approach to life sciences.
Highlights
-
Wasna featured in the South China Morning Post
19 January 2023
How Singapore’s deep-tech biomedical start-ups are growing rapidly – and helping to change the world.
-
The Slingshot 2022 Second Runner Up
30 October 2022
SLINGSHOT 2022 attracted applications from over 3,600 startups across more than 150 countries.
Wasna was selected as the second runner up and awarded 180K SGD of non-dilutive funding.
-
The Liveability Challenge 2022 Grand Finalist
9 June 2022
Following a 6-month journey and beating more than 400 other applicants from over 60 countries.
Wasna was selected as a Grand Finalist for the Liveability Challenge 2022.